Breast Cancer Clinical Trial
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Summary
The purpose of this study is to identify new chemotherapy treatment regimens with better response rates and to find out if the combination of docetaxel and capecitabine can shrink the size of breast tumors and preserve the breast.
Full Description
The purpose of this study is to identify new chemotherapy treatment regimens with better response rates and to find out if the combination of docetaxel and capecitabine can shrink the size of breast tumors and preserve the breast.
Induction chemotherapy offers the possibility of less surgery and determines tumor sensitivity in vivo. Previous trials have demonstrated that complete pathologic response in the breast at surgery corresponds with improved outcome. Additionally, we will correlate specific molecular markers in the breast tumors before and after chemotherapy, with response to treatment.
Expression of these molecular markets may be used in the future to predict the likelihood of response to chemotherapy given post-operatively.
Approximately 100 patients will participate at Emory Winship Cancer Institute and Emory Crawford W. Long Hospital and Grady Health System in Atlanta, Georgia.
Eligibility Criteria
Inclusion Criteria:
Histologically or cytologically confirmed breast carcinoma.
Early stage breast cancer (stage 1, 2, 3).
No evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
18 years of age or older.
Final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Exclusion Criteria:
Prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
Major surgery within 28 days of study entry.
Evidence of CNS metastases.
Final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Atlanta Georgia, 30303, United States More Info
Principal Investigator
Atlanta Georgia, 30308, United States More Info
Principal Investigator
Atlanta Georgia, 30322, United States More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.